Medical Advocates
Opportunistic Diseases
  Main Page

 New/Noteworthy
 OI Index
 General/Miscellaneous Reports
Epidemiology
Viral Load
OI Drugs
HAART and OIs
OI Prophylaxis
Treatment Guidelines
National Studies
Pediatric
OI Main Page Main New/Newsworthy Home Page      
Last Update:  July 15, 2008
.  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
       
July 2008
 
General Reports: Miscellaneous Studies
       

            Journal Papers, Abstracts, and Commentaries

  Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count
above 200/microl in the era of cART.
Podlekareva D, Mocroft A, Kirk O, et al
Scand J Infect Dis. 2008 Jun 18:1-6.
 Abstract
 
Susceptibility to opportunistic infections in HIV-infected patients with increased CD4
T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector
memory CD4 T cells and B cells.
French M, Keane N, McKinnon E, et al
HIV Med. 2007 Apr;8(3):148-55.
 Abstract
 
Factors associated with the development of opportunistic infections in HIV-1-infected adults
with high CD4+ cell counts: a EuroSIDA study.
Podlekareva D, Mocroft A, Dragsted UB,  
J Infect Dis. 2006 Sep 1;194(5):633-41
 Abstract
 
Contribution of T Cell Subsets to the Pathophysiology of Pneumocystis-Related Immunorestitution
Disease.
Bhagwat SP, Gigliotti F, Xu H, Wright TW.
Am J Physiol Lung Cell Mol Physiol. 2006 Aug 4;
Abstract
 
Opportunistic infection as a cause of transient viremia in chronically infected HIV patients
under treatment with HAART.
Jones E, Perelson AS.  
Bull Math Biol. 2005 Jul 13;
Abstract
 
Declining Gastrointestinal Opportunistic Infections in HIV-Infected Persons: A Triumph of
Science and a Challenge for Our HAARTs and Minds.
Raufman JP.
Am J Gastroenterol. 2005 Jul;100(7):1455-8.
 Abstract
 
Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active
antiretroviral therapy.
Monkemuller KE, Lazenby AJ, et al
 Dig Dis Sci. 2005 Feb;50(2):230-4.
 Abstract
 
FULL-TEXT PDF ARTICLE
Treatment of Opportunistic Infections
Bartlett JG
 The Hopkins HIV Report, November 2004 Vol 16. No 6
 Abstract

Opportunistic diseases in HIV infection
Furrer H.
LymphoidTher Umsch. 2004 Oct;61(10):625-30.
 Abstract

          Conference Reports, Abstracts, and Posters

  Opportunistic disease and mortality in patients co-infected with hepatitis C virus (HCV)
and/or hepatitis B virus (HBV) in the SMART (Strategic Management of Antiretroviral
Therapy) study
Tedaldi E, Puoti M, Neuhaus J, et al
 (4th IAS Conference)
 Abstract
Epidemiology (also refer to epidemiology for specific OIs)
       

            Journal Papers, Abstracts, and Commentaries

  Emerging trends in the epidemiology of invasive mycoses in England and Wales
(1990-9).
Lamagni TL, Evans BG, Shigematsu M, Johnson EM
Epidemiol Infect 2001 Jun;126(3):397-414
 Abstract

          Conference Reports, Abstracts, and Posters

 
POSTER
 The Burden of OI in Adults Receiving ART in Resource-limited Settings in Médecins
Sans Frontières-supported Projects
S Balkan, D O'Brien, P Humblet, et al
(14 CROI)
 PDF Poster     Abstract

HIV/AIDS - related opportunistic infections among women in poor resource
settings in Côte d'Ivoire
BD Soura
 (15IAC)
 Abstract
Viral Load
       

            Journal Papers, Abstracts, and Commentaries

  Viral load as an independent risk factor for opportunistic infections in HIV-infected
adults and adolescents.
Kaplan JE, Hanson DL, Jones JL, Dworkin MS.
AIDS. 2001 Sep 28;15(14):1831-6.
 Abstract
OI Drugs
       

Amphotericin B

               Journal Papers, Abstracts, and Commentaries

  Comparison of in vitro Antifungal Activities of Amphotericin B Lipid Complex with I
traconazole against 708 Clinical Yeast Isolates and Opportunistic Moulds Determined b
y National Committee for Clinical Laboratory Standards Methods M27-A and M38-P.
Carrillo-Munoz AJ, Ruesga M, Brio S, Del Valle O, et al
Chemotherapy 2002 Dec;48(5):224-231
 Abstract
 		  
Caspofungin

               Journal Papers, Abstracts, and Commentaries
 
  The use of caspofungin in HIV-infected individuals.
Waters L, Nelson M.
Expert Opin Investig Drugs. 2007 Jun;16(6):899-908.
Abstract


Cotrimoxazole

                Journal Papers, Abstracts, and Commentaries
 
  Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in
patients with previous history of hypersensitivity to cotrimoxazole.
Lin D, Li W, Rieder M.
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005646.
 Abstract

Itraconazole

               Journal Papers, Abstracts, and Commentaries

  Clinical experience with itraconazole in systemic fungal infections .
Boogaerts M, Maertens J.
 Drugs 2001;61 Suppl 1:39-47
 Abstract
 
Pentoxiphylline

               Journal Papers, Abstracts, and Commentaries
 
  Prevention of opportunistic infections in HIV infection by pentoxiphylline.
Wanchu A, Bhatnagar A, Bambery P, et al  
Indian J Med Res. 2006 Dec;124(6):705-8
 Abstract

HAART and OIs
       

        Journal Papers, Abstracts, and Commentaries

 

Safe interruption of maintenance therapy against previous infection with four common
HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Kirk O, Reiss P, Uberti-Foppa C, Bickel M, et al.
Ann Intern Med 2002 Aug 20;137(4):239-50
Abstract

  

OI Prophylaxis
       

General Reports

        Journal Papers, Abstracts, and Commentaries

  Effect of prophylaxis on the clinical manifestations of AIDS-related opportunistic
infections.
Sepkowitz KA.
Clin Infect Dis 1998 Apr;26(4):806-10 
Abstract
 

Resource-Affluent Countries Issues

Spain

        Journal Papers, Abstracts, and Commentaries
  Prevention of opportunistic infections in adult and adolescent patients with HIV infection.
GESIDA/National AIDS Plan guidelines, 2003.
Berenguer J, Laguna F, Lopez-Aldeguer J, et al.
Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76.
 Abstract

United States

        Journal Papers, Abstracts, and Commentaries

  Prophylaxis of opportunistic infections.
Tantisiriwat W, Powderly WG.
Infect Dis Clin North Am 2000 Dec;14(4):929-44
 Abstract

Resource-Limited Countries Issues

India

        Journal Papers, Abstracts, and Commentaries
 
  Prevention of opportunistic infections in HIV infection by pentoxiphylline.
Wanchu A, Bhatnagar A, Bambery P, et al  
Indian J Med Res. 2006 Dec;124(6):705-8
Abstract

West Africa

        Journal Papers, Abstracts, and Commentaries

 
Prevention of wasting and opportunistic infections in HIV-infected patients
in West Africa: a realistic and necessary strategy before antiretroviral treatment.
Ledru e, Sanou PT,Dembele M, Dahourou H, Zoubga A, Durand G.
Sante. 1999 Sep-Oct;9(5):293-300. 
 Abstract

Treatment/Prevention Guidelines
United States      

United States

            Journal Papers, Abstracts, and Commentaries

  FULL-TEXT ARTICLE
Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents:
Recommendations from CDC, the National Institutes of Health, and the HIV
Medicine Association/Infectious Diseases Society of America
MMWR Dec 17, 2004 / Vol. 53 / No. RR--15
 Paper

OI Main Page Main New/Newsworthy Home Page      

HIV Infection/Disease: OI Main Page